Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-016557
Filing Date
2026-05-13
Accepted
2026-05-13 09:09:44
Documents
77
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q veru20260331_10q.htm   iXBRL 10-Q 1215142
2 EXHIBIT 31.1 ex_923999.htm EX-31.1 9201
3 EXHIBIT 31.2 ex_924000.htm EX-31.2 9087
4 EXHIBIT 32.1 ex_924001.htm EX-32.1 6214
  Complete submission text file 0001437749-26-016557.txt   7276834

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA veru-20260331.xsd EX-101.SCH 62952
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE veru-20260331_cal.xml EX-101.CAL 47641
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE veru-20260331_def.xml EX-101.DEF 500123
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20260331_lab.xml EX-101.LAB 388990
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20260331_pre.xml EX-101.PRE 526652
81 EXTRACTED XBRL INSTANCE DOCUMENT veru20260331_10q_htm.xml XML 1161900
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

EIN.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 26971219
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)